Live Breaking News & Updates on Common Shares Of The Company Debenture

Stay updated with breaking news from Common shares of the company debenture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hemostemix Inc.: Hemostemix Announces $2,750,000 Convertible Debenture

Calgary, Alberta (Newsfile Corp. - March 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has signed a binding term sheet ....

Thomas Smeenk , Venture Exchange The , Common Shares Of The Company Debenture , Regulation Service Provider , Common Shares Of The Company , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Alberta Newsfile Corp , Venture Exchange , Board Of Directors The Company , Each Debenture Unit , Common Shares , Common Share , Market Price , Conversion Price , Each Debenture Warrant , Debenture Units , Debenture Warrants , Term Sheet , Debenture Offering , Minority Security Holders , Special Transactions , Business Corporations Act , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment ,

Hemostemix Inc.: Hemostemix Announces the Closing of a $2,500,000 Convertible Debenture

Calgary, Alberta (Newsfile Corp. - June 11, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it closed its previously announced ....

United States , South Africa , Thomas Smeenk , Delaware Federal Court , Venture Exchange The , Common Shares Of The Company Debenture , Regulation Service Provider , Common Shares Of The Company , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Company For Debenture Units , Florida State Court , Alberta Newsfile Corp , Venture Exchange , Board Of Directors The Company , Debenture Units , Each Debenture Unit , Common Shares , Common Share , Market Price , Conversion Price , Each Debenture Warrant , Debenture Offering , Debenture Warrants , Minority Security Holders , Special Transactions ,

Hemostemix : Announces the TSX Venture's Preliminary Approval of the Closing of a $2,500,000 Convertible Debenture at $0.40 per Unit and Corporate Update

Hemostemix Announces the TSX Venture s Preliminary Approval of the Closing of a $2,500,000 Convertible Debenture at $0.40 per Unit and Corporate Update

May 29, 2021

Calgary,. | May 30, 2021 ....

United States , Thomas Smeenk , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Polices Of The Exchange , Common Shares Of The Company Debenture , Venture Exchange , Common Shares Of The Company , Hemostemix Announces , Preliminary Approval , Corporate Update , Debenture Units , Financial Statements , Management Discussion , Debenture Offering , Debenture Unit , Each Debenture Unit , Debenture Warrant , Common Share , Common Shares , Debenture Warrants , Maturity Date , Debenture Shares , Conversion Price , Market Price , United States Securities Act ,

Hemostemix Inc.: Hemostemix Announces the TSX Venture's Preliminary Approval of the Closing of a $2,500,000 Convertible Debenture at $0.40 per Unit and Corporate Update

(0)
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Calgary, Alberta (Newsfile Corp. - May 29, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO.F) ( Hemostemix or the Company ) is pleased to announce that it has obtained preliminary approval from the TSX Venture Exchange to close a $2,500,000 convertible debenture order from a director for Debenture Units priced at $0.40 per Unit as detailed below. On May 28, 2021, Hemostemix filed its Financial Statements and Management Discussion and Analysis for the period ending March 31, 2020 on SEDAR.
This financing segregates the litigation risk from the equity risk and enables the Company to move forward with its business plans, stated Thomas Smeenk, CEO. ....

United States , Thomas Smeenk , Common Shares Of The Company Debenture , Regulation Service Provider , Common Shares Of The Company , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Polices Of The Exchange , Alberta Newsfile Corp , Venture Exchange , Debenture Units , Financial Statements , Management Discussion , Debenture Offering , Each Debenture Unit , Debenture Warrant , Common Share , Common Shares , Debenture Warrants , Market Price , Conversion Price , United States Securities Act , Minority Security Holders , Special Transactions , Ischemic Cardiomyopathy , Dilated Cardiomyopathy ,

Hemostemix Inc.: Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

Hemostemix Inc.: Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Thomas Smeenk , Venture Exchange The , Alberta Securities Commission Rule , United States District Court , Common Shares Of The Company Debenture , Regulation Service Provider , Common Shares Of The Company , World Economic Forum Technology Pioneer Award , Accudata Solutions Inc , Hemostemix Inc , Polices Of The Exchange , Alberta Newsfile Corp , Venture Exchange , Company Common Share , Health Sciences , Debenture Units , Unit Offering , Each Unit , Common Share , Common Shares , Each Finder , Existing Shareholder Exemption , Existing Shareholder , Investment Dealer Exemption , Debenture Offering ,